The alternative (“alt-“) animal products industry is growing increasingly more popular each year, causing an increased demand in foods madeContinue Reading Foodtech Patents: Who’s on the Board and What Moves are they Making?
Federal funding is a huge boon for companies, universities, and research institutions conducting innovative research. However, it comes attached with…Continue Reading Keeping Your Federally-Funded Inventions: Requirements to Comply with the Bayh-Dole Act
Gene therapies have been the subject of tremendous scientific research and investment. With hundreds of clinical trials in progress and…Continue Reading The Evolving Gene Editing Landscape: From Research Tool to Market
In a cautionary tale for inventors participating in trade shows and other non-confidential presentations, on February 15, 2023, the U.S.Continue Reading Patent Invalid Due to Trade Show Demonstration More Than One Year Before Filing Date
Substantial patent litigation activity occurred in the mRNA space in 2022, involving nearly all of the major mRNA and lipid…Continue Reading mRNA IP 2022 Year in Review: Pioneers Clash in Major Patent Litigations
Great buzz resulted from the World Bank study showing that the fashion industry is responsible for about 10% of annual…Continue Reading Upcycling: A Question of Law and Optics
Web3, the up-and-coming decentralized iteration of the World Wide Web built on the blockchain, presents a unique opportunity for fashion…
Continue Reading Fashion Meets Web3 – Protecting Emerging Phygital Fashion Innovations
Spurred by the vast potential of artificial intelligence (AI) and machine learning (ML) technologies, many countries are evaluating whether existing…
Continue Reading Will Divergent Copyright Laws Between the US and UK Influence Where You Do Business as an Artificial Intelligence Company?
Several patent litigations have been filed involving mRNA pioneers such as Moderna, Inc. and BioNTech, Inc. (with Pfizer) over the…
Continue Reading The Current mRNA/LNP Patent Litigation Landscape
On August 16, 2022, Merck (NYSE: MRK) and Orna Therapeutics each announced that they entered into a collaboration agreement relating…
Continue Reading Merck and Orna Therapeutics Join Forces in Circular RNA Collaboration